10 results  1 of 1 

1 Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers
Joseph J. Noh, Min Kyu Kim, Min Chul Choi, Jeong-Won Lee, Hyun Park, Sang Geun Jung, Won Duk Joo, Seung Hun Song, Chan Lee
Cancer Res Treat.2022;54(4):1200-1208.   Published online 2021 December 13     DOI: http://dx.doi.org/10.4143/crt.2021.828
      
2 Dietary inflammatory index and risk of gynecological cancers: a systematic review and meta-analysis of observational studies
Ze-ying Liu, Xu-ping Gao, Sui Zhu, Yan-hua Liu, Li-jun Wang, Chun-xia Jing, Fang-fang Zeng
J Gynecol Oncol.2019;30(3):e23.  Published online 2018 November 23     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e23
      
3 The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer
Randa J. Jalloul, Alpa M. Nick, Mark F. Munsell, Shannon N. Westin, Pedro T. Ramirez, Michael Frumovitz, Pamela T. Soliman
J Gynecol Oncol.2018;29(5):e68.  Published online 2018 May 4     DOI: http://dx.doi.org/10.3802/jgo.2018.29.e68
      
4 Supportive Care Needs of Patients with Gynecologic Cancer
Hyun Jung Lee, In Gak Kwon
Asian Oncol Nurs.2018;18(1):21-29.   Published online 2018 March 5     DOI: http://dx.doi.org/10.5388/aon.2018.18.1.21
   
5 Survival of gynecological cancers in Turkey: where are we at?
Murat Gultekin, Selin Dundar, Irem Kucukyildiz, Mujdegul Zayifoglu Karaca, Guledal Boztas, Semra Hatice Turan, Ezgi Hacikamiloglu, Bekir Keskinkilic
J Gynecol Oncol.2017;28(6):e85.  Published online 2017 November 4     DOI: http://dx.doi.org/10.3802/jgo.2017.28.e85
      
6 Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection
Baraem Yoo, Hyojeong Ahn, Miseon Kim, Dong Hoon Suh, Kidong Kim, Jae Hong No, Yong Beom Kim
Obstet Gynecol Sci.2017;60(5):440-448.   Published online 2017 September 18     DOI: http://dx.doi.org/10.5468/ogs.2017.60.5.440
      
7 Survival of gynecological cancers in Turkey: where are we at?
Murat Gultekin, Selin Dundar, Irem Kucukyildiz, Mujdegul Zayifoglu Karaca, Guledal Boztas, Semra Hatice Turan, Ezgi Hacikamiloglu, Bekir Keskinkilic
J Gynecol Oncol.2017;28(6):e85.  Published online 2017 September 9     DOI: http://dx.doi.org/10.3802/jgo.2017.28.e85
      
8 The epidemiologic status of gynecologic cancer in Thailand
Sarikapan Wilailak, Nuttapong Lertchaipattanakul
J Gynecol Oncol.2016;27(6):e65.  Published online 2016 October 10     DOI: http://dx.doi.org/10.3802/jgo.2016.27.e65
      
9 Effectiveness of PLISSIT Model Sexual Program on Female Sexual Function for Women with Gynecologic Cancer
Nami Chun
J Korean Acad Nurs.2011;41(4):471-480.   Published online 2011 August 31     DOI: http://dx.doi.org/10.4040/jkan.2011.41.4.471
      
10 Gynecological cancer in Indonesia
M. Farid Aziz
J Gynecol Oncol.2009;20(1):8-10.   Published online 2009 March 31     DOI: http://dx.doi.org/10.3802/jgo.2009.20.1.8
      

 1 of 1